1. Search Result
Search Result
Results for "

2,2',4,4',6,6'-Hexachlorobiphenyl-<sup>13</sup>C<sub>12</sub>

" in MedChemExpress (MCE) Product Catalog:

7

Inhibitors & Agonists

5

Peptides

2

Isotope-Labeled Compounds

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-W748345

    2,3',4,4',5,5'-Hexachlorobiphenyl-<sup>13sup>C<sub>12sub>

    Isotope-Labeled Compounds Others
    2,3',4,4',5,5'-Hexachloro-1,1'-biphenyl- 13C12 is 13C labeled 2,3',4,4',5,5'-Hexachloro-1,1'-biphenyl .
    2,3',4,4',5,5'-Hexachloro-1,1'-biphenyl-13C12
  • HY-W748354

    2,2',4,4',6,6'-Hexachlorobiphenyl-<sup>13sup>C<sub>12sub>

    Isotope-Labeled Compounds Others
    2,2',4,4',6,6'-Hexachloro-1,1'-biphenyl- 13C12 (2,2',4,4',6,6'-Hexachlorobiphenyl- 13C12) is 13C labeled 2,2',4,4',6,6'-Hexachloro-1,1'-biphenyl .
    2,2',4,4',6,6'-Hexachloro-1,1'-biphenyl-13C12
  • HY-P3350

    Bacterial Infection
    LS-BF1 is a stable and low toxic cationic antimicrobial peptide. LS-BF1 displays broad spectrum of antibacterial activity, including the challenging ESKAPE pathogens, by cell membrane disruptive mechanism. LS-BF1 shows good in vivo efficacy for elimination of bacteria in a mouse infection model[1].
    LS-BF1
  • HY-P1182

    Histone Methyltransferase Cancer
    C21 is a potent, irreversible, and selective PRMT1 inhibitor with an IC50 of 1.8 μM. C21 inhibits PRMT6 with an IC50 of 8.8 μM .
    C21
  • HY-P10579

    Ephrin Receptor Cancer
    123B9, a tumor-homing agent, is a potent and selective EphA2 agonist with a Kd value of 4.0 μM. 123B9 selectively targets the EphA2 tyrosine kinase receptor ligand-binding domain. 123B9 does not appreciably inhibit the ligand binding domains of the most closely related EphA3 and EphA4 receptors .
    123B9
  • HY-105168

    Endothelin Receptor Cardiovascular Disease
    TAK 044 is an antagonist of Endothelin Receptor. TAK 044 strongly inhibits ET-induced deterioration in various animal models. TAK 044 can be used in study ET-related diseases such as acute myocardial infarction,acute renal failure, acute hepatic malfunction, and subarachnoid hemorrhage .
    TAK 044
  • HY-P10563

    BHV-1100

    CD38 Cancer
    Noraramtide (BHV-1100) is an antibody recruitment molecule. Noraramtide can specifically bind to CD38 molecules to recruit natural killer (NK) cells. Noraramtide enhances the ability of NK cells to kill tumor cells through antibody-dependent cellular cytotoxicity (ADCC). This mechanism allows NK cells to more effectively recognize and eliminate tumor cells while avoiding mutual killing between NK cells. Noraramtide can be used for the study of autologous cancer immunity .
    Noraramtide

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: